A clinical trial to look at how safe different doses of mosunetuzumab are to give with or without atezolizumab in people with B-cell non-Hodgkin’s lymphoma or chronic lymphocytic leukaemia, how well they work, and how the body responds to and gets rid of the drugs

A Safety and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)